Clinical Trials in Los Angeles

Showing 761-780 of 13,631 trials

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369

This is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in HR+/HER2- advanced and metastatic breast cancer, with or without fulvestrant.

Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more

Atavistik Bio, Inc134 participantsStarted Jul 2025

Los Angeles, California, United States • Lake Mary, Florida, United States • Boston, Massachusetts, United States +5 more locations

TERMINATEDPhase 2< 1 mile

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

NCT06113328

Researchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-6194 and how well people tolerate it. Researchers also want to learn if people who take MK-6194 have more of a decrease in the amount of vitiligo on their face compared to people who take placebo.

Non-segmental Vitiligo

Merck Sharp & Dohme LLC169 participantsStarted Nov 2023

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Los Angeles, California, United States +65 more locations

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Find Trials by Condition in Los Angeles

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

Actinium Therapy for Late-stage Aggressive Sarcomas

Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Mucopolysaccharidosis VII Disease Monitoring Program

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Evolut™ EXPAND TAVR II Pivotal Trial

Empathic Communication Skills (ECS) Training

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

ELEVATE High-Risk PCI Pivotal Study

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies